ArticleDigestive diseases and sciences2025
Gastrointestinal Manifestations of Yao Syndrome (NOD2-Associated Autoinflammatory Disease).
Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Not getting the nod: The case against Yao syndrome.Journal of human immunity · 2026Review
- NOD2-Related Multisystem Inflammatory Disorders and Recent Advances.Current rheumatology reports · 2026Review
- Collagenous gastritis: current understanding of a rare immune-mediated gastropathy across pediatric and adult phenotypes-from pathogenesis to therapeutic strategies.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundYao syndrome (YAOS) is a NOD2-associated autoinflammatory disease characterized by periodic fevers, dermatitis, polyarthritis, swelling of the distal extremities, and gastrointestinal symptoms in patients with specific NOD2 variants. While gastrointestinal symptoms are a hallmark of the disease, little is known about specific symptoms and their underlying mechanisms.
methodsIn this study, we identified 24 patients with YAOS from an institutional YAOS databse. We evaluated their presenting gastrointestinal symptoms at initial presentation via the validated Gastrointestinal Symptom Rating Scale questionnaire, which 14 participants filled out. We then systematically analyzed all gastrointestinal-relevant blood work, stool studies, imaging, endoscopies, and motility testing.
resultsGastrointestinal symptoms were reported by 100% of patients, with the most prominent symptom being bloating. Most of the workup including stool testing, gastrointestinal-related bloodwork, and endoscopic examinations with biopsies was normal. Abdominopelvic radiographs and cross-sectional imaging studies were most often normal, although an excessive stool burden was commonly identified. A minority of patients had associated diagnoses of collagenous gastritis, celiac disease, autoimmune-like enteropathy, or microscopic colitis. Gastric and colonic motility testing was normal in most patients; however, anorectal manometry with balloon expulsion testing was abnormal in 100% of tested patients. A minority of patients had hepatic steatosis or benign liver lesions.
conclusionsGastrointestinal symptoms of YAOS are universal and severe, and symptoms may arise from both inflammatory and non-inflammatory mechanisms. Bloating and constipation may be driven by dyssynergic defecation.
Indexed as
Identifiers
40711739What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.